News Release – 2018 | News Release | Hisamitsu Pharmaceutical co.,inc.

2018.12.17: Notification of a New Drug Application for HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

2018.12.14: Notification of the results of Phase III clinical study in opioid analgesic naive patients of the transdermal, pain management patch FENTOS®TAPE (development code:HFT-290)

2018.11.28: Notification of listing on the NHI drug price standard and marketing of a new dose “0.5 mg” of ‘Fentos® Tape (Development code: HFT-290)’ ,Transdermal, Pain management patch

2018.11.09: Notification of approval for manufacturing and marketing approval of OABLOK®PATCH in Taiwan (Transdermal, Overactive bladder treatment patch)

2018.10.22: Notification of the commencement of the Phase II clinical study of HP-5070 in Japan (a transdermal drug for the treatment of primary local hyperhidrosis)

2018.10.10: FY02/2019 Q2 Results Earnings Release Presentation

2018.09.28: Notification of application for manufacturing and marketing approval of HP-3000 (Transdermal, Parkinson’s disease treatment patch) in Japan

2018.07.06: FY02/2019 Q1 Results Earnings Release Presentation

2018.07.02: Notification of approval of supplemental new drug application (NDA) for the addition of a new 0.5mg dose of the transdermal, pain management patch FENTOS® TAPE (development code: HFT-290)

2018.05.18: Salonpas Named the World’s No.1 OTC Topical Analgesic Patch Brand for the Second Consecutive Year

2018.04.26: Noven Pharmaceuticals, Inc. press release :Noven Announces Successful Resolution of FDA Warning Letter

2018.04.10: FY02/2018 Q4 Results Earnings Release Presentation

2018.03.28: Notice of Revision of Financial Forecast

2018.02.27: Notification of the results of Phase III clinical study of HP-3000 in Japan (a transdermal drug for the treatment of Parkinson’s disease)

2018.02.08: Announcement of Establishment of New Company

2018.02.06: Hisamitsu Pharmaceutical, Becomes an Official Partner (External Pain Relief Products) of the Olympic and Paralympic Games Tokyo 2020!

2018.01.31: Notification of the results of the Phase III clinical study of HP-3070 (transdermal patch for the treatment of schizophrenia) in the US

2018.01.19: Notification of the approval of a manufacturing and marketing for ALLESAGA® TAPE (Development Code: HP-3060) in Japan, a transdermal system for the treatment of allergic rhinitis.

2018.01.12: FY02/2018 Q3 Results Earnings Release Presentation